Thalidomide usage in Wales: The need to follow guidelines

British Journal of Dermatology

Volumn 144, Issue 2, 2001, Pages 310-315

  Chave, T A ^a,b   Finlay, A Y ^a   Knight, A G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Guidelines; Peripheral neuropathy; Teratogenicity; Thalidomide

Indexed keywords

THALIDOMIDE;

ARTICLE; BEHCET DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DRUG INDICATION; DRUG SAFETY; DRUG USE; HUMAN; PEMPHIGUS VULGARIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN DISEASE; TERATOGENICITY; UNITED KINGDOM;

DERMATOLOGIC AGENTS; DERMATOLOGY; DRUG UTILIZATION; GUIDELINE ADHERENCE; HUMANS; INFORMED CONSENT; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SKIN DISEASES; TERATOGENS; THALIDOMIDE; WALES;

EID: 0035110796     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04020.x     Document Type: Article

References (32)

1. Thalidomide in autoimmune conditions
2. Thalidomide in the treatment of lepra reactions
3. The treatment of lepra reactions in lepromatous leprosy: Fifteen years' experience with thalidomide
4. Thalidomide effects in Behçet's syndrome and pustular vasculitis
5. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus
6. Thalidomide in actinic prurigo
7. Treatment of prurigo nodularis with thalidomide
8. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide
9. Thalidomide in severe orogenital ulceration
10. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis
11. Thalidomide for the treatment of uraemic pruritus: A crossover randomized double-blind trial
12. Thalidomide for the treatment of oral aphthous ulcers in patients with HIV infection
13. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers
14. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placeho-controlled clinical trial
15. Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre
16. Thalidomide inhibits the replication of human immunodeficiency virus type 1
17. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
18. Thalidomide neuropathy: A clinical, electrophysiological and histological follow-up study
19. Development of polyneuropathy during thalidomide therapy
20. Thalidomide and exfoliative dermatitis
21. Erthyroderma due to thalidomide: Report of two cases
22. Thalidomide-induced toxic pustuloderma
23. Motorische Leitungsgeschwindigkeit der Kubitalnerven bei Patienten mit Leprareaktion
24. Neuropathy after thalidomide ('Distival')
25. Thalidomide-induced peripheral neuropathy
26. Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditions
27. Thalidomide neuropathy: An electrophysiologic study
28. Thalidomide neuropathy: Incidence and clinicoelectrophysiologic findings in 42 patients
29. Licht- und elektronenmikroskopische Untersuchung zum Spätstudium der thalidomid-Polyneuropathie
30. Thalidomide-induced peripheral neuropathy: A prospective clinical, neurophysiological and pharmacogenetic evaluation
31. Guidelines for the clinical use and dispensing of thalidomide
32. STEPS : A comprehensive program for controlling and monitoring access to thalidomide